Oliver Schreiner

769 citations
11 papers · 135 indexed · h-index 7
Topics
Dermatological and COVID-19 studies (3 papers)Skin Diseases and Diabetes (2 papers)Long-Term Effects of COVID-19 (2 papers)
Journals
The LancetSHILAP Revista de lepidopterologíaThe American Journal of Medicine
Partner nations
GermanyUnited States

In The Last Decade

Oliver Schreiner

11 papers receiving 130 citations

Peers

Oliver Schreiner
Comparison fields: 5 of 49
  • Surgery 35
  • Nephrology 32
  • Infectious Diseases 28
  • Rheumatology 28
  • Molecular Biology 20
Replace Alexandre Favà with:
Alexandre Favà Spain
Nikola Milinić Serbia
Dzifa Dey Ghana
Carme Facundo Spain
Sarat Kuppachi United States
Veronica Batani Italy
Sebastián Ibañez Chile
J.C. Regueiro López Spain
Jackie Lever United States
B Bourgeon France
Oliver Schreiner relative to Alexandre Favà Spain Alexandre Favà's profile →
Citations per field
00.5×
Alexandre Favà · 1×
Citations per year

Countries citing papers authored by Oliver Schreiner

Since Specialization
Citations

This map shows the geographic impact of Oliver Schreiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Schreiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Schreiner more than expected).

Fields of papers citing papers by Oliver Schreiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Schreiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Schreiner. The network helps show where Oliver Schreiner may publish in the future.

Co-authorship network of co-authors of Oliver Schreiner

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Schreiner. A scholar is included among the top collaborators of Oliver Schreiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Schreiner. Oliver Schreiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 3
2 29
3 10
4 4
5 4
6 6
7 8
8 1
9 21
10 17
11 32

About Oliver Schreiner

Oliver Schreiner is a scholar working on Equine, Dermatology and Nephrology, having authored 11 papers that have together received 135 indexed citations. Recurring topics across this work include Dermatological and COVID-19 studies (3 papers), Skin Diseases and Diabetes (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Nephrology (32 citations), Hepatology (15 citations) and Rheumatology (28 citations). Oliver Schreiner has collaborated with scholars based in Germany and United States. Frequent co-authors include Peter R. Galle, E Wandel, Elisabeth Märker‐Hermann, MF Neurath, Thomas Höhler, Markus Bosmann, H Köhler, U Denzer, Martin Holtmann and Karl J. Lackner. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026